<DOC>
	<DOCNO>NCT00000776</DOCNO>
	<brief_summary>To evaluate effect corticosteroid reduce elevated intracranial pressure cryptococcal meningitis . To evaluate safety corticosteroid patient cryptococcal meningitis intracranial hypertension . In AIDS patient cryptococcal meningitis , correlation find early death elevate intracranial pressure . Since dexamethasone find reduce intracranial pressure result form meningitis , may benefit AIDS patient cryptococcal meningitis .</brief_summary>
	<brief_title>Dexamethasone Cryptococcal Meningitis</brief_title>
	<detailed_description>In AIDS patient cryptococcal meningitis , correlation find early death elevate intracranial pressure . Since dexamethasone find reduce intracranial pressure result form meningitis , may benefit AIDS patient cryptococcal meningitis . Patients randomize receive dexamethasone placebo every 6 hour 72 hour ( day 1 3 ) . Additionally , standard antifungal therapy amphotericin B flucytosine give 2 week , follow fluconazole 8 week . Lumbar puncture perform daily day 1 3 , day 7 14 , week 10 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<mesh_term>Flucytosine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Aerosolized pentamidine systemic chemoprophylaxis PCP . Preventive therapy steroidassociated ulcer therapy require manage steroid toxicity ( e.g. , insulin ) . Patients must : Documented initial episode relapse acute cryptococcal meningitis . ( NOTE : Patients must untreated episode except administration test dose 1 g less amphotericin B . ) Acute cryptococcal meningitis cerebrospinal fluid opening pressure &gt; = 250 mm H2O prior receipt antifungal therapy episode . Documented HIV infection OR diagnosis AIDS base document AIDSdefining opportunistic infection . Ability begin therapy within 8 hour preentry lumbar puncture . Consent parent guardian le 18 year age . NOTE : Comatose patient eligible provide informed consent provide guardian next kin . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Concurrent CNS disease another infection neoplasm would interfere assessment response . Prison incarceration . Concurrent Medication : Excluded : Acetazolamide , mannitol , urea preparation , corticosteroid first 72 hour study . Treatment prophylaxis systemic antifungal agent time . Antiretroviral therapy first 72 hour study . Prior Medication : Excluded within 7 day prior study entry : Corticosteroids , mannitol , urea preparation , acetazolamide , 24 hour phenytoin .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Meningitis</keyword>
	<keyword>Cryptococcosis</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Flucytosine</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Amphotericin B</keyword>
	<keyword>Brain Diseases</keyword>
</DOC>